Dr. Luis Gosálbez

Managing Director and Co-Founder

​

Microbiome drug development: Historical pipeline analysis reveals promising areas & bottlenecks

​

Dr. Luis Gosálbez presents the first-ever analysis of microbiome drug development success rates based on the historical pipeline. The analysis provides preliminary insights on what therapeutic applications and drug modalities seem to be more promising, while highlighting the bottlenecks in microbiome drug development.